Lenalidomide
Showing 976 - 1000 of 1,173
Anemia, Multiple Myeloma, Plasma Cell Tumor Trial in Cleveland (epoetin alfa)
Completed
- Anemia
- +2 more
- epoetin alfa
-
Cleveland, OhioCase Comprehensive Cancer Center
Jan 24, 2018
Multiple Myeloma Trial in Riyadh (Lenalidomide/Low dose Dex, Bortezomib/Lenalidomide/ Low dose Dex, Lenalidomide)
Completed
- Multiple Myeloma
- Lenalidomide/Low dose Dex
- +2 more
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital &Reseach Center
Feb 24, 2016
Ovarian Cancer Recurrent Trial in Paris (Lenalidomide)
Completed
- Ovarian Cancer Recurrent
- Lenalidomide
-
Paris, FranceHopital Tenon
Mar 15, 2016
Acute Myelogenous Leukemia Trial in Boston (Lenalidomide, Mitoxantrone, Etoposide)
Completed
- Acute Myelogenous Leukemia
- Lenalidomide
- +3 more
-
Boston, Massachusetts
- +2 more
Mar 15, 2016
Quality of Life in Relapsed/Refractory Multiple Myeloma When
Completed
- Multiple Myeloma
-
Stockholm, SwedenKarolinska Institute
Mar 24, 2016
Multiple Myeloma Trial in Torino (Revlimid, Melphalan, Prednisone, Thalidomide)
Completed
- Multiple Myeloma
- Revlimid, Melphalan, Prednisone, Thalidomide
-
Torino, Italy/Torino, ItalyAzienda Ospedaliera S Giovanni Battista
May 9, 2016
T-cell Lymphoma Trial in Canada (Lenalidomide)
Completed
- T-cell Lymphoma
- Lenalidomide
-
Calgary, Alberta, Canada
- +4 more
Mar 14, 2016
Multiple Myeloma Trial in Nieuwegein, Amsterdam, Utrecht (Lenalidomide, endoxan, prednisone, lenalidomide, endoxan, prednisone)
Completed
- Multiple Myeloma
- Lenalidomide, endoxan, prednisone
- lenalidomide, endoxan, prednisone
-
Nieuwegein, Utrecht, Netherlands
- +2 more
Feb 25, 2016
Multiple Myeloma Trial in Indianapolis (lenalidomide (Revlimid®), Cyclophosphamide, Prednisone)
Completed
- Multiple Myeloma
- lenalidomide (Revlimid®)
- +2 more
-
Indianapolis, IndianaIndiana University Cancer Center
May 12, 2016
Multiple Myeloma Trial in United States (Anti-CXCR4 (BMS-936564), Lenalidomide, Dexamethasone)
Completed
- Multiple Myeloma
- Anti-CXCR4 (BMS-936564)
- +3 more
-
Tampa, Florida
- +3 more
Mar 15, 2016
B-cell Chronic Lymphocytic Leukemia Trial in Houston (B-CLL Vaccine, Lenalidomide)
Terminated
- B-cell Chronic Lymphocytic Leukemia
- B-CLL Vaccine
- Lenalidomide
-
Houston, TexasHouston Methodist Hospital
Feb 5, 2016
Prophylaxis and Treatment of Arterial and Venous Thromboembolism
Completed
- Hematologic Neoplasm
- +4 more
- Observation
-
Alessandria, Italy
- +22 more
Mar 21, 2018
Lymphoma, Multiple Myeloma Trial in Saint-Etienne (Tinzaparin, Blood sample)
Completed
- Lymphoma
- Multiple Myeloma
- Tinzaparin
- Blood sample
-
Saint-Etienne, FranceCHU de Saint-Etienne
May 10, 2017
Multiple Myeloma Trial in Baltimore (Imetelstat (7.5 mg/kg), lenalidomide standard of care, Imetelstat (9.4 mg/kg))
Completed
- Multiple Myeloma
- Imetelstat (7.5 mg/kg)
- +2 more
-
Baltimore, Maryland
- +1 more
Apr 13, 2016
MDS Trial in Scottsdale, St. Louis (Lenalidomide)
Completed
- Myelodysplastic Syndromes
- Lenalidomide
-
Scottsdale, Arizona
- +1 more
Nov 30, 2015
Relapsed and Refractory Multiple Myeloma Trial in United States (Ixazomib)
Completed
- Relapsed and Refractory Multiple Myeloma
-
Tampa, Florida
- +4 more
Jun 19, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in New York (biological, drug, genetic, other)
Terminated
- Multiple Myeloma and Plasma Cell Neoplasm
- rituximab
- +4 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 19, 2015
Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse Trial in United
Completed
- Relapsed and Bortezomib Refractory Multiple Myeloma
- +2 more
- panobinostat
- +2 more
-
Los Angeles, California
- +12 more
Nov 27, 2017
Acute Myeloid Leukemia Trial in Angers (azacitidine, Lenalidomide)
Completed
- Acute Myeloid Leukemia
- azacitidine
- Lenalidomide
-
Angers, FranceMathilde HUNAULT BERGER
Mar 15, 2016
Chronic Lymphocytic Leukemia Trial in Charleston, Greenville (Ofatumumab, Lenalidomide)
Completed
- Chronic Lymphocytic Leukemia
- Ofatumumab
- Lenalidomide
-
Charleston, South Carolina
- +1 more
Nov 2, 2015